Accepted for Publication: December 3, 2018.
Corresponding Author: Jennifer F. Waljee, MD, MPH, MS, Department of Surgery, University of Michigan Medical School, 1500 E Medical Center Dr, 2130 Taubman Center, Ann Arbor, MI 48109 (filip@med.umich.edu).
Published Online: February 27, 2019. doi:10.1001/jamasurg.2018.5838
Author Contributions: Drs Harbaugh and Waljee had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Ms Kenney conducted and is responsible for the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: Harbaugh, Chua, Kenney, Iwashyna, Brummett, Waljee.
Drafting of the manuscript: Harbaugh, Chua, Brummett, Waljee.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Harbaugh, Chua, Kenney, Iwashyna.
Obtained funding: Brummett, Waljee.
Administrative, technical, or material support: Englesbe, Brummett, Waljee.
Supervision: Englesbe, Brummett, Waljee.
Conflict of Interest Disclosures: Dr Brummett reports a patent for peripheral perineural dexmedetomidine licensed to University of Michigan, being a paid consultant for Recro Pharma and Heron Therapeutics Inc (not related to the present work), and receiving research funding from Neuros Medical Inc. Dr Waljee reports receiving research funding from the Agency for Healthcare Research and Quality, the American College of Surgeons, and the American Foundation for Surgery of the Hand and serving as an unpaid consultant for 3M Health Information systems. No other disclosures were reported.
Funding/Support: This study was funded by grant E20180568-001 from the Substance Abuse and Mental Health Services Administration and grant E20180672-00 from the Centers for Medicare & Medicaid Services (Drs Englesbe, Brummett, and Waljee).
Role of the Funder/Sponsor: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of Substance Abuse and Mental Health Services Administration, the Michigan Department of Health and Human Services, the US government, or the US Department of Veterans Affairs.
6.Bennett
KG, Harbaugh
CM, Hu
HM,
et al. Persistent opioid use among children, adolescents, and young adults after common cleft operations.
J Craniofac Surg. 2018;29(7):1697-1701.
PubMedGoogle Scholar 12.Elmallah
RK, Ramkumar
PN, Khlopas
A,
et al. Postoperative pain and analgesia: is there a genetic basis to the opioid crisis?
Surg Technol Int. 2018;32:306-314.
PubMedGoogle Scholar 16.Pestka
EL, Craner
J, Evans
M,
et al. Impact of family history of substance abuse on admission opioid dose, depressive symptoms, and pain catastrophizing in patients with chronic pain.
Pain Manag Nurs. 2018;19(2):115-124. doi:
10.1016/j.pmn.2017.09.007PubMedGoogle ScholarCrossref 18.Voepel-Lewis
T, Zikmund-Fisher
BJ, Smith
EL, Zyzanski
S, Tait
AR. Parents’ preferences strongly influence their decisions to withhold prescribed opioids when faced with analgesic trade-off dilemmas for children: a prospective observational study.
Int J Nurs Stud. 2015;52(8):1343-1353. doi:
10.1016/j.ijnurstu.2015.05.003PubMedGoogle ScholarCrossref 21.Nasseh
K, Vujicic
M, Glick
M. The relationship between periodontal interventions and healthcare costs and utilization: evidence from an integrated dental, medical, and pharmacy commercial claims database.
Health Econ. 2017;26(4):519-527. doi:
10.1002/hec.3316PubMedGoogle ScholarCrossref 23.Feudtner
C, Feinstein
JA, Zhong
W, Hall
M, Dai
D. Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation.
BMC Pediatr. 2014;14:199. doi:
10.1186/1471-2431-14-199PubMedGoogle ScholarCrossref 26.Bohnert
AS, Ilgen
MA, Trafton
JA,
et al. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009.
Clin J Pain. 2014;30(7):605-612.
PubMedGoogle Scholar 28.Meier
MH, Hall
W, Caspi
A,
et al. Which adolescents develop persistent substance dependence in adulthood? using population-representative longitudinal data to inform universal risk assessment.
Psychol Med. 2016;46(4):877-889. doi:
10.1017/S0033291715002482PubMedGoogle ScholarCrossref